Chromosome 1p loss: A favorable prognostic factor in low-grade gliomas

Annals of Neurology

Volumn 58, Issue 2, 2005, Pages 322-326

  Kujas, Michèle ^a,b   Lejeune, Julie ^a   Benouaich Amiel, Alexandra ^b   Crinière, Emmanuelle ^a   Laigle Donadey, Florence ^b   Marie, Yannick ^a   Mokhtari, Karima ^a,b   Polivka, Marc ^c   Bernier, Michèle ^d   Chretien, Fabrice ^e   Couvelard, Anne ^f   Capelle, Laurent ^b   Duffau, Hugues ^b   Cornu, Philippe ^b   Broët, Philippe ^g   Thillet, Joëlle ^a   Carpentier, Antoine F ^a,b   Sanson, Marc ^a,b   Hoang Xuan, Khê ^a,b   Delattre, Jean Yves ^a,b,h  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d FOCH HOSPITAL   (France)

^e HENRI MONDOR HOSPITAL   (France)

^f BEAUJON HOSPITAL   (France)

^g HÔPITAL PAUL BROUSSE   (France)

^h Service de Neurologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHROMOSOME 10Q; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME 9P; CHROMOSOME LOSS; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE COURSE; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GLIOMA; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; SEIZURE; SEX RATIO; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; FEMALE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MOLECULAR BIOLOGY;

EID: 23244449700     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20543     Document Type: Article

References (14)

1. von Deimling A, Eibl RH, Ohgaki H, et al. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res 1992;52:2987-2990.
2. Reifenberger J, Reifenberger G, Liu L, et al. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994;145:1175-1190.
3. Kleihues. Pathology and genetics. Tumours of the nervous system-WHO classification of tumours. Lyon, France: IARC Press, 2000.
4. He J, Mokhtari K, Sanson M, et al. Glioblastomas with an oligodendroglial component: a pathological and molecular study. J Neuropathol Exp Neurol 2001;60:863-871.
5. Mueller W, Hartmann C, Hoffmann A, et al. Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. Am J Pathol 2002;161:313-319.
6. Ueki K, Nishikawa R, Nakazato Y, et al. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Clin Cancer Res 2002;8:196-201.
7. Okamoto Y, Di Patre PL, Burkhard C, et al. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathol (Berl) 2004;108:49-56.
8. Maintz D, Fiedler K, Koopmann J, et al. Molecular genetic evidence for subtypes of oligoastrocytomas. J Neuropathol Exp Neurol 1997;56:1098-1104.
9. Jeuken JW, Sprenger SH, Boerman RH, et al. Subtyping of oligo-astrocytic tumours by comparative genomic hybridization. J Pathol 2001;194:81-87.
10. Shaw E, Arusell R, Scheithauer B, et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 2002;20:2267-2276.
11. Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002;20:2076-2084.
12. Karim AB, Maat B, Hatlevoll R, et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 1996; 36:549-556.
13. Karim AB, Afra D, Cornu P, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 2002; 52:316-324.
14. Hoang-Xuan K, Capelle L, Kujas M, et al. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 2004;22:3133-3138.